NCT01104415 - Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 15, 2010

Primary Completion Date

February 12, 2014

Study Completion Date

February 12, 2014

Conditions

Carcinoid Syndrome

Interventions

DRUG

Telotristat etiprate

Telotristat etiprate capsules orally three times daily.

Trial Locations (10)

Lexicon Investigational Site, Bad Berka

Lexicon Investigational Site, Berlin

Lexicon Investigational Site, Halle

Lexicon Investigational Site, Lübeck

Lexicon Investigational Site, Marburg

Lexicon Investigational Site, Munich

Lexicon Investigational Site, Basingstoke

Lexicon Investigational Site, Cambridge

Lexicon Investigational Site, London

Lexicon Investigational Site, Manchester